Literature DB >> 23776205

Phosphorylation-triggered CUEDC2 degradation promotes UV-induced G1 arrest through APC/C(Cdh1) regulation.

Wei-Na Zhang1, Jie Zhou, Tao Zhou, Ai-Ling Li, Na Wang, Jin-Jing Xu, Yan Chang, Jiang-Hong Man, Xin Pan, Tao Li, Wei-Hua Li, Rui Mu, Bing Liang, Liang Chen, Bao-Feng Jin, Qing Xia, Wei-Li Gong, Xue-Min Zhang, Li Wang, Hui-Yan Li.   

Abstract

DNA damage triggers cell cycle arrest to provide a time window for DNA repair. Failure of arrest could lead to genomic instability and tumorigenesis. DNA damage-induced G1 arrest is generally achieved by the accumulation of Cyclin-dependent kinase inhibitor 1 (p21). However, p21 is degraded and does not play a role in UV-induced G1 arrest. The mechanism of UV-induced G1 arrest thus remains elusive. Here, we have identified a critical role for CUE domain-containing protein 2 (CUEDC2) in this process. CUEDC2 binds to and inhibits anaphase-promoting complex/cyclosome-Cdh1 (APC/C(Cdh1)), a critical ubiquitin ligase in G1 phase, thereby stabilizing Cyclin A and promoting G1-S transition. In response to UV irradiation, CUEDC2 undergoes ERK1/2-dependent phosphorylation and ubiquitin-dependent degradation, leading to APC/C(Cdh1)-mediated Cyclin A destruction, Cyclin-dependent kinase 2 inactivation, and G1 arrest. A nonphosphorylatable CUEDC2 mutant is resistant to UV-induced degradation. Expression of this stable mutant effectively overrides UV-induced G1-S block. These results establish CUEDC2 as an APC/C(Cdh1) inhibitor and indicate that regulated CUEDC2 degradation is critical for UV-induced G1 arrest.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23776205      PMCID: PMC3703968          DOI: 10.1073/pnas.1221009110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

2.  Nek10 mediates G2/M cell cycle arrest and MEK autoactivation in response to UV irradiation.

Authors:  Larissa S Moniz; Vuk Stambolic
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

Review 3.  p21 stability: linking chaperones to a cell cycle checkpoint.

Authors:  Geng Liu; Guillermina Lozano
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

4.  The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates.

Authors:  Claudine Kraft; Hartmut C Vodermaier; Sebastian Maurer-Stroh; Frank Eisenhaber; Jan-Michael Peters
Journal:  Mol Cell       Date:  2005-05-27       Impact factor: 17.970

5.  Rapid destruction of human Cdc25A in response to DNA damage.

Authors:  N Mailand; J Falck; C Lukas; R G Syljuâsen; M Welcker; J Bartek; J Lukas
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

6.  Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.

Authors:  Xin Pan; Tao Zhou; Yan-Hong Tai; Chenguang Wang; Jie Zhao; Yuan Cao; Yuan Chen; Pei-Jing Zhang; Ming Yu; Cheng Zhen; Rui Mu; Zhao-Fang Bai; Hui-Yan Li; Ai-Ling Li; Bing Liang; Zhao Jian; Wei-Na Zhang; Jiang-Hong Man; Yan-Fei Gao; Wei-Li Gong; Li-Xin Wei; Xue-Min Zhang
Journal:  Nat Med       Date:  2011-05-15       Impact factor: 53.440

7.  Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1.

Authors:  G Fang; H Yu; M W Kirschner
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

8.  CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.

Authors:  Wei-Na Zhang; Li Wang; Qiong Wang; Xue Luo; Di-Feng Fang; Yuan Chen; Xin Pan; Jiang-Hong Man; Qing Xia; Bao-Feng Jin; Wei-Hua Li; Tao Li; Bing Liang; Liang Chen; Wei-Li Gong; Ming Yu; Ai-Ling Li; Tao Zhou; Hui-Yan Li
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

9.  Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1.

Authors:  Hui-Yan Li; Hui Liu; Chen-Hui Wang; Ji-Yan Zhang; Jiang-Hong Man; Yan-Fei Gao; Pei-Jing Zhang; Wei-Hua Li; Jie Zhao; Xin Pan; Tao Zhou; Wei-Li Gong; Ai-Ling Li; Xue-Min Zhang
Journal:  Nat Immunol       Date:  2008-03-23       Impact factor: 25.606

Review 10.  The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression.

Authors:  R Wäsch; J A Robbins; F R Cross
Journal:  Oncogene       Date:  2009-10-12       Impact factor: 9.867

View more
  10 in total

1.  A genome-wide association study of autism using the Simons Simplex Collection: Does reducing phenotypic heterogeneity in autism increase genetic homogeneity?

Authors:  Pauline Chaste; Lambertus Klei; Stephan J Sanders; Vanessa Hus; Michael T Murtha; Jennifer K Lowe; A Jeremy Willsey; Daniel Moreno-De-Luca; Timothy W Yu; Eric Fombonne; Daniel Geschwind; Dorothy E Grice; David H Ledbetter; Shrikant M Mane; Donna M Martin; Eric M Morrow; Christopher A Walsh; James S Sutcliffe; Christa Lese Martin; Arthur L Beaudet; Catherine Lord; Matthew W State; Edwin H Cook; Bernie Devlin
Journal:  Biol Psychiatry       Date:  2014-09-30       Impact factor: 13.382

2.  CUE domain-containing protein 2 promotes the Warburg effect and tumorigenesis.

Authors:  Xiuying Zhong; Shengya Tian; Xiang Zhang; Xinwei Diao; Fangting Dong; Jie Yang; Zhaoyong Li; Linchong Sun; Lin Wang; Xiaoping He; Gongwei Wu; Xin Hu; Lihua Wang; Libing Song; Huafeng Zhang; Xin Pan; Ailing Li; Ping Gao
Journal:  EMBO Rep       Date:  2017-03-21       Impact factor: 8.807

3.  The Insulin Receptor Adaptor IRS2 is an APC/C Substrate That Promotes Cell Cycle Protein Expression and a Robust Spindle Assembly Checkpoint.

Authors:  Sandhya Manohar; Qing Yu; Steven P Gygi; Randall W King
Journal:  Mol Cell Proteomics       Date:  2020-06-18       Impact factor: 5.911

4.  Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas.

Authors:  Aichun Wang; Chao Guo; Yunfei Sun; Lijuan Lu; Yun Wang; Qiong Wang; Yan Zhang; Hui Zhang; Li Wang; Yiqun Gu; Aijun Liu
Journal:  J Cancer       Date:  2015-04-29       Impact factor: 4.207

5.  CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma.

Authors:  Longhua Sun; Lihong Bai; Gengpeng Lin; Ran Wang; Yangli Liu; Jinghuang Cai; Yubiao Guo; Zhiwen Zhu; Canmao Xie
Journal:  Oncotarget       Date:  2015-08-21

6.  CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway.

Authors:  Feng Li; Chuanxi Tang; Dan Jin; Li Guan; Yue Wu; Xinfeng Liu; Xiuxiang Wu; Qing Yun Wu; Dianshuai Gao
Journal:  Int J Oncol       Date:  2017-05-17       Impact factor: 5.650

7.  CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis.

Authors:  Shuyan Han; Huifeng Hao; Haibo Han; Dong Xue; Yanna Jiao; Yuntao Xie; Ye Xu; Longtao Huangfu; Jialei Fu; Shan Wang; Hong Sun; Pingping Li; Qun Zhou
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

8.  CUEDC2 modulates cardiomyocyte oxidative capacity by regulating GPX1 stability.

Authors:  Zhao Jian; Bing Liang; Xin Pan; Guang Xu; Sai-Sai Guo; Ting Li; Tao Zhou; Ying-Bin Xiao; Ai-Ling Li
Journal:  EMBO Mol Med       Date:  2016-07-01       Impact factor: 12.137

Review 9.  The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression.

Authors:  Cordell VanGenderen; Troy Anthony Alan Harkness; Terra Gayle Arnason
Journal:  Aging (Albany NY)       Date:  2020-08-15       Impact factor: 5.682

Review 10.  Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives.

Authors:  Sara La Manna; Ilaria De Benedictis; Daniela Marasco
Journal:  Front Mol Biosci       Date:  2022-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.